Taylor Steve L
Food Allergy Research and Resource Program, University of Nebraska, Lincoln, Nebraska 68583-0919, USA.
Annu Rev Pharmacol Toxicol. 2002;42:99-112. doi: 10.1146/annurev.pharmtox.42.082401.130208.
Foods produced through agricultural biotechnology are reaching the consumer marketplace. These novel foods should be assessed for their safety, including their potential allergenicity. Agricultural biotechnology involves the introduction of novel proteins into the modified foods, and proteins can be allergenic. The potential allergenicity of the introduced proteins can be evaluated by focusing on the source of the gene, the homology of the newly introduced protein to known allergens, the reactivity of the novel protein with IgE antibodies from the serum of individuals with known allergies to the source of the transferred DNA or to materials that are broadly related to the source of the transferred DNA, the resistance of the novel protein to pepsin, and the immunoreactivity of the novel protein in appropriate animal models. Additional factors, such as the level of expression of the novel protein in the modified food and expression in the edible portion of the food, may also yield valuable insights. Applying such criteria provides a reasonable approach to determining whether or not the novel protein is likely to become an allergen.
通过农业生物技术生产的食品正在进入消费市场。这些新型食品应进行安全性评估,包括其潜在的致敏性。农业生物技术涉及将新型蛋白质引入改良食品中,而蛋白质可能具有致敏性。可以通过关注基因来源、新引入蛋白质与已知过敏原的同源性、新型蛋白质与已知对转移DNA来源或与转移DNA来源广泛相关物质过敏个体血清中的IgE抗体的反应性、新型蛋白质对胃蛋白酶的抗性以及新型蛋白质在适当动物模型中的免疫反应性来评估引入蛋白质的潜在致敏性。其他因素,如新型蛋白质在改良食品中的表达水平以及在食品可食用部分的表达,也可能提供有价值的见解。应用这些标准为确定新型蛋白质是否可能成为过敏原提供了一种合理的方法。